Tricho-rhino-phalangeal syndrome Type 1
Tricho-rhino-phalangeal syndrome Type 1 (TRPS1) is a rare genetic disorder characterized by distinctive craniofacial and skeletal abnormalities. Patients with TRPS1 typically present with sparse scalp hair (trichorrhexis), a bulbous nose, long flat philtrum, thin upper lip, and cone-shaped epiphyses leading to shortening of the phalanges, the bones in the fingers and toes. This condition is also associated with short stature and various degrees of intellectual disability.
Etiology[edit]
TRPS1 is caused by mutations in the TRPS1 gene located on chromosome 8 (8q24.12). This gene plays a crucial role in the development and differentiation of various tissues, including bone and hair follicles. Mutations in the TRPS1 gene lead to the production of a dysfunctional protein that disrupts normal development, resulting in the characteristic features of the syndrome.
Clinical Features[edit]
The clinical manifestations of TRPS1 can vary significantly among affected individuals but generally include:
- Craniofacial Features: Sparse scalp hair, a bulbous tip of the nose, a long flat philtrum, and a thin upper lip.
- Skeletal Abnormalities: Short stature, cone-shaped epiphyses of the phalanges, and hip malformations.
- Dental Anomalies: Delayed eruption of teeth and malocclusion.
- Intellectual Disability: Varies from none to mild or moderate.
Diagnosis[edit]
Diagnosis of TRPS1 is primarily based on clinical evaluation and the characteristic physical findings. Genetic testing can confirm the diagnosis by identifying a mutation in the TRPS1 gene. Radiographic imaging may reveal cone-shaped epiphyses and other skeletal abnormalities that support the diagnosis.
Management[edit]
There is no cure for TRPS1, and management focuses on treating the symptoms and improving the quality of life for affected individuals. This may include:
- Orthopedic Interventions: To address skeletal abnormalities and improve mobility.
- Dental Care: To manage dental anomalies and improve oral health.
- Hair Care: Specialized care and treatments for hair abnormalities.
- Educational Support: For those with intellectual disabilities.
Prognosis[edit]
The prognosis for individuals with TRPS1 varies depending on the severity of the symptoms. With appropriate management, most individuals can lead a normal life, although they may face challenges related to their physical and, in some cases, intellectual disabilities.
Epidemiology[edit]
TRPS1 is a rare disorder, with an estimated prevalence of less than 1 in 1,000,000 live births worldwide. It affects males and females equally.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian